Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pne… (NCT04636554) | Clinical Trial Compass
NO_LONGER_AVAILABLENot Applicable
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
Plain-language summary
Phage Treatment in Covid-19 Patients with Bacterial Co-Infections
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Covid-19 patients with pneumonia or bacteremia/septicemia who have culture-confirmed bacterial co-infection with A. baumannii, P. aeruginosa or S. aureus.
* Patient provided informed and signed consent.
Exclusion Criteria:
* Patient eligible for another APT sponsored trial.
* Patient participating in another clinical trial at the same time or patients \< 4 weeks from participating in an alternative investigational protocol/study
* Patient with known allergy to infusion of phage products
* Patients with a history of Meningitis or encephalitis at time of study entry, Primary immune deficiency disease or tuberculosis or Stroke, transient ischemic attack (TIA), or untreated deep vein thrombosis.